title: [Recommendations before travelling for renal transplant patients].
abstract: Travel is now a reasonable objective of CKD patients after renal transplantation. However, immunosuppressive treatment makes them particularly susceptible to infections and may interfere with vaccinations and other drugs. Travel in countries with low health level should be strongly discouraged in the first six months after transplantation or following an acute event. Otherwise, specific consultations should be arranged to prepare the patient as soon as possible. Vaccinations should be started early before departure. Specific immunisations include vaccines against hepatitis A, typhoid, meningococcus and rabies in some cases. Living vaccines are formally contra-indicated. Particular attention should be paid for protection against insects because this is the only effective measure against diseases. In the case of malaria, it should be complemented by adapted chemoprophylaxis that should be started 15 days before the departure date. Advice on hygiene measures should be clarified because this can prevent numerous infections, especially of the digestive tract. Advice on the management of diarrhoea is essential, especially in terms of preventing dehydration. Finally, advice about transport and physical risks, especially those related to sun exposure, should also be addressed.
authors.affiliation: Service de néphrologie-dialyse-transplantation rénale, Nouvel hôpital civil, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg, France. stephane.bally@yahoo.fr
authors.forename: Stéphane
authors.initials: S
authors.lastname: Bally
authors.forename: Sophie
authors.initials: S
authors.lastname: Caillard
authors.forename: Bruno
authors.initials: B
authors.lastname: Moulin
mesh_terms: D000349:Africa; D006801:Humans; D006920:Hygiene; D007115:Immunization Schedule; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections / Q000453:epidemiology / Q000209:etiology; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D010353:Patient Education as Topic; D018570:Risk Assessment; D013020:South America; D014195:Travel
chemical_list: D007166:Immunosuppressive Agents